Advertisement
Research Article| Volume 22, P115-119, May 2018

Download started.

Ok

Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23)

      Highlights

      • Unemployment is a significant problem for people with multiple sclerosis (pwMS).
      • The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) is a useful self-report tool that examines work-related problems in pwMS across three domains: physical, psychological/cognitive, and external barriers.
      • Employment-associated factors need to be assessed to optimize workplace and raise awareness among employers about the special needs of pwMS. The Spanish version of the MSWDQ-23 shows appropriate feasibility, reliability, and discriminative performance in clinical practice as a patient-reported outcome.

      Abstract

      Introduction

      Unemployment is a significant problem for people with multiple sclerosis (MS). The MS Work Difficulties Questionnaire (MSWDQ-23) is a self-report tool to assess work-related problems in people with MS across three domains: physical, psychological/cognitive, and external barriers. The aim of this study was to assess the psychometric properties of the Spanish version of the MSWDQ-23.

      Methods

      A multicentre, non-interventional, cross-sectional study in adult patients with relapsing-remitting multiple sclerosis (RRMS) or primary progressive (PPMS) multiple sclerosis (McDonald 2010 criteria) was conducted. Socio-demographic and clinical characteristics as well as health-related quality of life using the 29-item Multiple Sclerosis Impact Scale (MSIS-29) were collected.

      Results

      A total of 201 subjects were studied (mean age: 43.9 years, 60% female, 86% with RRMS). Median Expanded Disability Status Scale (EDSS) (score: 2.0 [IQR: 1.0–3.5]). The employment rate was 47.3% (n = 95). The MSWDQ-23 was feasible (90% response rate), with high internal consistency and test-retest reliability (Cronbach's alpha = 0.94 and intraclass correlation coefficient-ICC > 0.87). MSWDQ-23 scores significantly and positively correlated with EDSS and both MSIS-29 physical and psychological subscales scores, showing an adequate convergent validity. Regarding construct validity, scores of patients with PPMS were higher than those of patients with RRMS, reaching statistically significance in MSWDQ-23 physical barriers domain and total scores.

      Conclusion

      The Spanish version of the MSWDQ-23 shows appropriate feasibility, reliability, and discriminative performance as a patient-reported outcome. MSWDQ-23 may be a valuable addition to measure the impact of a comprehensive spectrum of difficulties experienced by people with MS in the workplace.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Candeliere-Merlicco A.
        • Valero-Delgado F.
        • Martínez-Vidal S.
        • et al.
        Prevalence of multiple sclerosis in Health District III, Murcia.
        Spain Mult. Scler. Relat. Disord. 2016; 9: 31-35
        • Chiaravalloti N.D.
        • DeLuca J.
        Cognitive impairment in multiple sclerosis.
        Lancet Neurol. 2008; 7: 1139-1151
        • Fernández O.
        • Fernández V.
        • Guerrero M.
        • et al.
        Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture-recapture method.
        Mult. Scler. 2012; 18: 372-376
        • Giovannoni G.
        Can we afford not to prevent MS-related disability?.
        Mult. Scler. 2017; 23: 1048-1049
        • Hobart J.
        • Lamping D.
        • Fitzpatrick R.
        • et al.
        The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
        Brain J. Neurol. 2001; 124: 962-973
        • Honan C.A.
        • Brown R.F.
        • Hine D.W.
        • et al.
        The multiple sclerosis work difficulties questionnaire.
        Mult. Scler. 2012; 18: 871-880
        • Honan C.A.
        • Brown R.F.
        • Hine D.W.
        • et al.
        The multiple sclerosis work difficulties questionnaire (MSWDQ): development of a shortened scale.
        Disabil. Rehabil. 2014; 36: 635-641
        • Honan C.A.
        • Brown R.F.
        • Batchelor J.
        Perceived cognitive difficulties and cognitive test performance as predictors of employment outcomes in people with multiple sclerosis.
        J. Int. Neuropsychol. Soc. 2015; 21: 156-168
        • Howard J.
        • Trevick S.
        • Younger D.S.
        Epidemiology of multiple sclerosis.
        Neurol. Clin. 2016; 34: 919-939
        • Karampampa K.
        • Gustavsson A.
        • Miltenburger C.
        Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
        Mult. Scler. 2012; 18 (Suppl 2): 7-15
        • Kobelt G.
        • Berg J.
        • Lindgren P.
        • et al.
        Costs and quality of life of patients with multiple sclerosis in Europe.
        J. Neurol. Neurosurg. Psychiatry. 2006; 77: 918-926
        • Kobelt G.
        • Thompson A.
        • Berg J.
        • et al.
        New insights into the burden and costs of multiple sclerosis in Europe.
        Mult. Scler. 2017; 23: 1123-1136
        • Lu L
        • Beadnall H.N.
        • Barton J.
        The evolution of no evidence of disease activity in multiple sclerosis.
        Mult. Scler. Relat. Disord. 2017; (Epub ahead of print)
        • Martínez-Ginés M.L.
        • García-Domínguez J.M.
        • Sarmiento M.
        Spanish cultural adaptation of the short version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23).
        Neurologia. 2017; (Epub ahead of print)
        • Merkel B.
        • Butzkueven H.
        • Traboulsee A.L.
        • et al.
        Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: a systematic review.
        Autoimmun. Rev. 2017; 16: 658-665
        • Miller A.
        • Dishon S.
        Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status.
        Qual. Life Res. 2006; 15: 259-271
      1. MS International Federation, 2016. Global MS Employment Report. 〈www.msif.org/wp-content/uploads/2016/05/Global-MS-Employment-Report-2016.pdf〉.

        • Polman C.H.
        • Reingold S.C.
        • Banwell B.
        • et al.
        Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria.
        Ann. Neurol. 2011; 69: 292-302
        • Raggi A.
        • Covelli V.
        • Schiavolin S.
        • et al.
        Work-related problems in multiple sclerosis: a literature review on its associates and determinants.
        Disabil. Rehabil. 2016; 38: 936-944
        • Rocca M.A.
        • Riccitelli G.C.
        • Meani A.
        Cognitive reserve, cognition, and regional brain damage in MS: a 2-year longitudinal study.
        Mult. Scler. 2018; (Epub ahead of print)
        • Salter A.
        • Thomas N.
        • Tyry T.
        • et al.
        Employment and absenteeism in working-age persons with multiple sclerosis.
        J. Med. Econ. 2017; 20: 493-502
        • Sicras-Mainar A.
        • Ruíz-Beato E.
        • Navarro-Artieda R.
        • et al.
        Impact on healthcare resource utilization of multiple sclerosis in Spain.
        BMC Health Serv. Res. 2017; 17: 854
        • Sterz C.
        • Ellenberger D.
        • Meißner H.
        • et al.
        Employment-associated factors in multiple sclerosis: results from a cross-sectional study in Germany.
        Edorium. J. Disabil. Rehabil. 2016; 2: 24-33
        • Sumowski J.F.
        • Leavitt V.M.
        Cognitive reserve in multiple sclerosis.
        Mult. Scler. 2013; 19: 1122-1127